President and CEO of ARDEA BIOSCIENCES, INC. (RDEA, Financial) Barry D Quart sells 20,000 shares of RDEA on 12/08/2010 at an average price of $21.92 a share.
Ardea Biosciences, Inc. has a market cap of $518.2 million; its shares were traded at around $22.35 with and P/S ratio of 22.7.
RDEA is in the portfolios of Stanley Druckenmiller of Duquesne Capital Management, LLC, Pioneer Investments.
Ardea Biosciences, Inc. has a market cap of $518.2 million; its shares were traded at around $22.35 with and P/S ratio of 22.7.
RDEA is in the portfolios of Stanley Druckenmiller of Duquesne Capital Management, LLC, Pioneer Investments.
CEO Recent Trades:
- Sell: President and CEO Barry D Quart sold 20,000 shares of RDEA stock on 08/09/2010 at the average price of 20.21. Barry D Quart owns at least 41,858 shares after this. The price of the stock has increased by 10.59% since.
Directors and Officers Recent Trades:
- Sell: SVP, Regulatory & Dev Ops Kimberly Manhard sold 5,000 shares of RDEA stock on 11/29/2010 at the average price of 22.24. Kimberly Manhard owns at least 4,044 shares after this. The price of the stock has increased by 0.49% since.
- Sell: EVP & COO Stephen Davis sold 351 shares of RDEA stock on 11/22/2010 at the average price of 21.92. Stephen Davis owns at least 25,117 shares after this. The price of the stock has increased by 1.96% since.
- Sell: SVP, Regulatory & Dev Ops Kimberly Manhard sold 5,000 shares of RDEA stock on 10/28/2010 at the average price of 21.03. Kimberly Manhard owns at least 3,700 shares after this. The price of the stock has increased by 6.28% since.
- Sell: SVP, Regulatory & Dev Ops Kimberly Manhard sold 5,000 shares of RDEA stock on 09/28/2010 at the average price of 23.03. Kimberly Manhard owns at least 3,700 shares after this. The price of the stock has decreased by 2.95% since.
- Sell: Director John Poyhonen sold 4,000 shares of RDEA stock on 09/23/2010 at the average price of 23.02. The price of the stock has decreased by 2.91% since.
